SOURCE: Intrexon Corporation

Intrexon Corporation

November 28, 2011 07:00 ET

Prior CEOs of Monsanto and Pfizer Join Intrexon Board of Directors

BLACKSBURG, VA--(Marketwire - Nov 28, 2011) - Intrexon Corporation, a privately held synthetic biology engineering company, today announced the appointments of Robert B. Shapiro and Jeffrey B. Kindler to the Intrexon Board of Directors.

Mr. Shapiro brings extensive experience in the biochemical and biological sciences industry where he served as former Vice President, President, and CEO of Monsanto, in addition to serving as Chairman and CEO of the NutraSweet subsidiary of GD Searle & Company. He received a B.A. from Harvard University in 1959 and J.D. from Columbia University School of Law in 1962.

Mr. Kindler joins the Intrexon Board following his immediate past tenure as Chairman and CEO of Pfizer, Inc. Preceding his leadership of Pfizer, Mr. Kindler served as the Executive Vice President and General Counsel of McDonald's Corporation. He received a B.A. from Tufts University in 1977, followed by a J.D. magna cum laude from Harvard University in 1980.

Intrexon's Chairman and CEO Randal J. Kirk welcomes Mr. Shapiro and Mr. Kindler stating, "Intrexon has reached a strategic execution phase that will be greatly enhanced by guidance from Bob and Jeff. I am very pleased that executives of this caliber and experience have accepted our invitation and look forward to gaining the full benefit of their experience and insights."

About Intrexon Corporation
Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive engineering platform and capabilities to rapidly design and produce novel biofunctions and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. The company's advanced industrial engineering platform enables Better DNA™ technology by combining revolutionary DNA control systems with corresponding advancements in modular transgene design, assembly and optimization. More information about the company is available at

Contact Information

  • Contact:
    Andrew Udell
    Intrexon Corporation
    Phone: 301-556-9850
    E-mail: Email Contact